Global Loss of Libido Treatment Market, By Treatment (Flibanserin, Bremelanotide, Hormone Therapy, Counseling, Others), Diagnosis (Blood Tests, Pelvic Exam, Others), Symptoms (Depression, Anxiety, Fatigue, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Loss of Libido Treatment Market
Loss of libido treatment market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 5% in the above mentioned forecast period.
Loss of libido is defined as decrease in sex drive which occurs due to psychological issues or medical conditions. It is a type of sexual dysfunction which affects both men and women. This condition is characterised by depression, anxiety and fatigue. Low testosterone levels in men, menopause in women, dyspareunia, various chronic disorders, low self-esteem, aging, stress and certain medications such as antidepressants are the causes of this condition.
The rise in the incidences of smoking, obesity, anxiety, depression, type 2 diabetes and heart diseases and high use of medications such as antidepressants, corticosteroids, antifungal and opioid pain relievers are the major factors influencing the market growth rate. Also, growing utilization of chemotherapy or radiation treatments for cancer, growing government funding and rising initiatives by government and private organisations to spread awareness about the disease and its available treatment are the factors that will expand the loss of libido treatment market.
Rise in the research and development activities and emerging new markets will provide beneficial opportunities for the loss of libido treatment market in the forecast period of 2021-2028.
However, high cost of treatment and lack of awareness are the factors that will hinder the market growth and will further challenge the loss of libido treatment market in the forecast period mentioned above.
This loss of libido treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the loss of libido treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Loss of Libido Treatment Market Scope and Market Size
The loss of libido treatment market is segmented on the basis of treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of treatment, the loss of libido treatment market is segmented into flibanserin, bremelanotide, hormone therapy, counseling and others.
- On the basis of diagnosis, the loss of libido treatment market is segmented into blood tests, pelvic exam and others.
- On the basis of symptoms, the loss of libido treatment market is segmented into depression, anxiety, fatigue and others.
- On the basis of dosage, the loss of libido treatment market is segmented into tablet, injection and others.
- On the basis of route of administration, the loss of libido treatment market is segmented into oral, intravenous and others.
- On the basis of end-users, the loss of libido treatment market is segmented into clinic, hospital and others.
The loss of libido treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Loss of Libido Treatment Market Country Level Analysis
The loss of libido treatment market is segmented on the basis of treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel.
The countries covered in the loss of libido treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the loss of libido treatment market due to the presence of major key players, high healthcare expenditure and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Loss of libido treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Loss of Libido Treatment Market Share Analysis
Loss of libido treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global loss of libido treatment market research.
The major players covered in the loss of libido treatment market report are Century Pharmaceuticals Ltd., Apicore LLC, Shodhana Laboratories Limited, Beloor Bayir, aasraw, Rakshit Drugs Private Limited, and SYMED LABS, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-